The neuroprotective effect of latanoprost acts via klotho‐mediated suppression of calpain activation after optic nerve transection

Latanoprost was first developed for use in glaucoma therapy as an ocular hypotensive agent targeting the prostaglandin F2α (FP) receptor. Subsequently, latanoprost showed a neuroprotective effect, an additional pharmacological action. However, although it is well‐known that latanoprost exerts an ocu...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Neurochem
Egile Nagusiak: Yamamoto, Kotaro, Sato, Kota, Yukita, Masayoshi, Yasuda, Masayuki, Omodaka, Kazuko, Ryu, Morin, Fujita, Kosuke, Nishiguchi, Koji M., Machida, Shigeki, Nakazawa, Toru
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2016
Gaiak:
ORIGINAL ARTICLES
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5299490/
https://ncbi.nlm.nih.gov/pubmed/27859240
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jnc.13902
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak